Jade Biosciences, Inc. (JBIO)
16.57
+0.17
(+1.04%)
USD |
NASDAQ |
Nov 11, 16:00
16.57
0.00 (0.00%)
After-Hours: 17:23
Jade Biosciences Market Cap : 1.053B for Nov. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 10, 2026 | 1.042B |
| November 09, 2026 | 991.48M |
| November 06, 2026 | 957.79M |
| November 05, 2026 | 896.14M |
| November 04, 2026 | 955.88M |
| November 03, 2026 | 926.01M |
| November 02, 2026 | 885.34M |
| October 30, 2026 | 893.60M |
| October 29, 2026 | 905.04M |
| October 28, 2026 | 927.28M |
| October 27, 2026 | 936.82M |
| October 26, 2026 | 921.56M |
| October 23, 2026 | 927.28M |
| October 22, 2026 | 947.62M |
| October 21, 2026 | 961.60M |
| October 20, 2026 | 944.44M |
| October 19, 2026 | 878.98M |
| October 16, 2026 | 856.10M |
| October 15, 2026 | 874.53M |
| October 14, 2026 | 854.19M |
| October 13, 2026 | 852.92M |
| October 12, 2026 | 889.79M |
| October 09, 2026 | 914.57M |
| October 08, 2026 | 899.32M |
| October 07, 2026 | 875.17M |
| Date | Value |
|---|---|
| October 06, 2026 | 852.29M |
| October 05, 2026 | 894.23M |
| October 02, 2026 | 897.41M |
| October 01, 2026 | 875.17M |
| September 30, 2026 | 892.96M |
| September 29, 2026 | 901.23M |
| September 28, 2026 | 912.03M |
| September 25, 2026 | 916.48M |
| September 24, 2026 | 936.18M |
| September 23, 2026 | 934.91M |
| September 22, 2026 | 1.065B |
| September 21, 2026 | 1.064B |
| September 18, 2026 | 1.077B |
| September 17, 2026 | 1.089B |
| September 16, 2026 | 1.058B |
| September 15, 2026 | 1.105B |
| September 14, 2026 | 1.155B |
| September 11, 2026 | 1.137B |
| September 10, 2026 | 1.216B |
| September 09, 2026 | 1.211B |
| September 08, 2026 | 1.236B |
| September 04, 2026 | 1.265B |
| September 03, 2026 | 1.262B |
| September 02, 2026 | 1.360B |
| September 01, 2026 | 1.336B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.172B |
| Alnylam Pharmaceuticals, Inc. | 21.39B |
| Anika Therapeutics, Inc. | 186.31M |
| Savara, Inc. | 1.021B |
| Vericel Corp. | 3.036B |
Market Cap Related Metrics
| Price to Book Value | 2.394 |
| Price | 16.57 |
| Earnings Yield | -15.77% |